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Background: The exercise capacity of adults with congenital heart disease (CHD) is often depressed, and the education of adults with CHD 
regarding the potential benefits of exercise is suboptimal. The effectiveness of formal exercise training programs in this population has not been 
assessed. The purpose of this study was to assess the impact of an exercise prescription program upon the exercise capacity of adults with CHD.
Methods: 18 adult patients aged 37±13 years (range 21-56 years) with a variety of CHD’s (tetralogy repair: 5; Senning: 2; Fontan: 2; 
physiologically corrected transposition: 2; other: 7), underwent an initial cardiopulmonary exercise test (CPET) and were then provided with a 
prescription for a self-administered exercise program. The prescription instructed the patients to exercise at an intensity sufficient to raise their 
heart rates to levels approximately equivalent to those associated with their ventilatory anaerobic threshold (identified on the CPET) for at least 20 
minutes, 3 times/week. CPET’s were repeated 10±5 months after the initial CPET. Subjects were divided into “compliant” and “non-compliant” groups 
on the basis of their responses to questions administered at the time of the follow-up CPET.
Results: Peak VO2 averaged 19.0±7.1 ml/kg/min on the initial CPET and 19.4±7.2 on the follow-up CPET (p=NS). Those that were compliant 
increased their peak VO2 from 20.1±9.3 to 21.5±9.1 ml/kg/min (p=0.025). In contrast, the peak VO2 of the non-compliant group decreased from 
17.7±3.2 to 17.1±3.3 ml/kg/min (p=NS). Improvements in peak VO2 of at least 1.0 ml/kg/min were observed in 7/9 compliant patients and 
in only 1/8 non-compliant patients (p<0.02). Compliant patients also achieved an average weight loss of 0.58±3.8 kg, whereas non-compliant 
patients gained an average of 0.65±1.8 kg.
Conclusions: When adults with CHD adhere to an exercise prescription, improvements in peak VO2 are often achieved, and successful weight loss 
is sometimes realized. Poor compliance with exercise prescriptions is common, and limits the effectiveness of this therapeutic intervention.
